Refine by
Cancer Therapy Articles & Analysis
226 articles found
Surgical intervention remains a cornerstone, often involving lumpectomy or mastectomy depending on tumor size, stage, and patient preferences. Adjuvant therapies may include radiation, chemotherapy, and targeted therapy. The choice of therapy typically hinges on the tumor’s receptor status and specific genetic mutations. For instance, ...
Ongoing studies are exploring their potential in cancer immunotherapy, gene therapy, and as platforms for diagnostic applications. ...
Post-transcriptional modifications of RNA molecules include methylation, acetylation deamination, isomerization, glycosylation, thiolation and pseudouracil modification among other types. Methylation represents the predominant post-transcriptional modification found within transfer RNA (tRNA) molecules. tRNA methylation has maintained its evolutionary conservation while also exhibiting dynamic ...
The Importance of Kinase Screening Kinases are implicated in a myriad of diseases, particularly cancer, where their dysregulation leads to uncontrolled cell proliferation. Targeting specific kinases has become a promising strategy for developing more effective and selective cancer therapies. Kinase screening services assist researchers in ...
Adenoviruses are a group of viruses that have gained significant attention in recent years, particularly in the fields of gene therapy, vaccine development, and cancer treatment. With their ability to deliver genetic material into cells effectively, adenoviruses serve as valuable vectors in various biomedical applications. ...
When it comes to interventional procedures, the ability to accurately and precisely target tissue structures has always been a challenge. However, in today's ever-evolving medical landscape, innovation is on the rise – one of which is platinum-iridium, marker bands. Built with advanced technology and customizable features, platinum-iridium marker bands are revolutionizing how physicians ...
Antibody-drug conjugates (ADCs) combine potent small-molecule drugs with monoclonal antibodies for targeted cancer therapy. A major challenge is loading enough drug onto each antibody without compromising solubility or circulation time. ...
As research advances, next-generation PEGylation techniques promise safer, more effective therapies for diverse diseases, from cancer to chronic inflammatory conditions. ...
As a result, current studies are exploring combination therapies that target multiple nodes in the apoptotic network. For example, research from the MD Anderson Cancer Center has shown that dual inhibition of both BCL2 and MCL1 can be effective in preclinical models of multiple myeloma. ...
A single missing fucose residue can enhance antibody-dependent cellular cytotoxicity by 50-fold, revolutionizing cancer immunotherapy approaches. The analytical challenge is immense. ...
Cancer treatment has witnessed transformative advancements over the past few decades, notably with the emergence of CAR-T (Chimeric Antigen Receptor T-cell) therapy. This revolutionary therapy harnesses the body's immune system by genetically engineering T-cells to target and destroy cancer cells. ...
Alfa Cytology has revealed new FAP-targeted therapeutics development services that aim to develop precise and effective cancer treatments. Alfa Cytology has introduced its groundbreaking initiative which targets fibroblast activation protein(FAP) for cancer therapies. ...
This method is particularly useful in identifying genetic abnormalities associated with cancer, such as gene amplifications, deletions, and translocations, which can play a critical role in the diagnosis and treatment planning of cancer patients. ...
Researchers are increasingly focused on engineering antibodies that can selectively target specific cancer cells or diseased tissues while minimizing off-target effects. ...
Surface engineering of platelets has led to significant advancements in cancer therapy approaches. Platelet Membrane-Coated Biomimetic Nanoparticles for Drug Delivery Platelet membrane-coated nanoparticles have good application value. ...
Through strategic partnerships, Alfa Cytology strengthens its position in oncology by working to create advanced ADCs therapies that could revolutionize cancer treatment methods. Alfa Cytology provides essential tools for cancer research advancement through the ADCs design services along with therapeutic antibody development and diagnostic ...
In recent years, the fight against cancer has seen significant advances, particularly with the emergence of targeted therapy. ...
Applications of Single-Domain Antibodies Single-domain antibodies have a wide array of applications across multiple fields: Therapeutics: They are being explored as potential treatments for various diseases, including cancer, infectious diseases, and autoimmune disorders, due to their ability to specifically target antigens. ...
Antibody-Drug Conjugates (ADCs) represent a groundbreaking advancement in targeted cancer therapy, combining the specificity of antibodies with the potency of cytotoxic drugs. ...
The Safety and Biocompatibility of Platinum Iridium Markers Platinum Iridium Markers are an essential aspect of modern medical treatment, particularly in the field of radiation therapy. They serve as a reference point for accurately delivering radiation doses to cancerous cells. ...